M&A Deal Summary

Vectura Acquires Activaero

On March 13, 2014, Vectura acquired life science company Activaero for 130M EUR

Acquisition Highlights
  • This is Vectura’s 1st transaction in the Life Science sector.
  • This is Vectura’s 0th largest (disclosed) transaction.
  • This is Vectura’s 1st transaction in Germany.

M&A Deal Summary
Date 2014-03-13
Target Activaero
Sector Life Science
Buyer(s) Vectura
Deal Type Add-on Acquisition
Deal Value 130M EUR

Target

Activaero

Gemünden, Germany
Activaero GmbH is a pharmaceutical company focused on the development of products for the treatment of respiratory diseases. Its proprietary smart nebuliser-based technology (FAVORITE) allows drug deposition into targeted areas of the lung and is currently utilised in seven clinical and several preclinical stage programmes.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Vectura

Chippenham, United Kingdom
Category Company
Founded 1997
Sector Life Science
Revenue 191M GBP (2020)
DESCRIPTION

Vectura is a provider of innovative inhaled drug delivery solutions that enable partners to bring their medicines to patients. The company has thirteen key inhaled and eleven non inhaled products marketed by major global pharmaceutical partners and a diverse portfolio of partnerships for drugs in clinical development. Vectura was founded in 1997 and is based in Chippenham, United Kingdom.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Germany) 1 of 1
Year (2014) 1 of 1
Mergr

Product

Company

Legal